GLP-1 clinical trials in Ohio: 31 recruiting now
47 sites in 16 Ohio cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- SnagRxSponsored$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
- MedviSponsored$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up
Weight-loss studies (9)
Weight-loss study of tirzepatide
Where: Cincinnati, Cleveland and Columbus
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 11 with obesity.
Call the site: 216-636-2828Study record on ClinicalTrials.gov
Cincinnati Children's Hospital Medical Center, Cincinnati
Cleveland Clinic, Cleveland. 216-636-2828
Nationwide Children's Hospital, Columbus
Weight-loss study of orforglipron
Where: Cleveland and Columbus
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Call the site: 216-636-2828Study record on ClinicalTrials.gov
Cleveland Clinic, Cleveland. 216-636-2828
Nationwide Children's Hospital, Columbus
Weight-loss study of cagrilintide
Where: Columbus and Dayton
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
Centricity Research - Ohio, Columbus
PriMed Clinical Research, Dayton
Show 6 more studies
Weight-loss study of cagrisema
Where: Maumee
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Advanced Medical Research, Maumee
Weight-loss study of tirzepatide
Where: Cincinnati
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with obesity lose weight.
Free to join
Who can join: Adults 18+ with obesity.
Study record on ClinicalTrials.gov
Velocity Clinical Research, Mt. Auburn, Cincinnati
Weight-loss study of LY3305677
Where: Cincinnati
What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.
Free to join
Who can join: Adults 18 to 75 with obesity, BMI 27+.
Call the site: 513-721-3868Study record on ClinicalTrials.gov
CTI Clinical Research Center, Cincinnati. 513-721-3868
Weight-loss study
Where: Clevland
Free to join
Who can join: Adults 18 to 80 with obesity or overweight, BMI 27+.
Call the site: 216-844-5965Study record on ClinicalTrials.gov
University Hospitals Cleveland Medical Center, Clevland. 216-844-5965
Weight-loss study
Where: Clevland
Free to join
Who can join: Adults 18 to 80 with obesity or overweight, BMI 27+.
Call the site: 216-844-5965Study record on ClinicalTrials.gov
University Hospitals Cleveland Medical Center, Clevland. 216-844-5965
Weight-loss study of tirzepatide
Where: Columbus
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight.
Call the site: 614-247-9650Study record on ClinicalTrials.gov
The Ohio State University, Columbus. 614-247-9650
Type 2 diabetes studies (7)
Type 2 diabetes study of survodutide
Where: Canton, Maumee and Wadsworth
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Diabetes & Endocrinology Associates of Stark County, Canton. 833-602-2368
Advanced Medical Research - Maumee, Maumee. 833-602-2368
New Venture Medical Research, Wadsworth. 833-602-2368
Type 2 diabetes study of semaglutide
Where: Columbus
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Columbus
Type 2 diabetes study of cagrisema
Where: Maumee
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 25+.
Study record on ClinicalTrials.gov
Advanced Medical Research, Maumee
Show 4 more studies
Type 2 diabetes study of LY3457263
Where: Dayton
What: Tests whether an investigational medicine from Lilly, LY3457263, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes, BMI 27+.
Call the site: 937-297-8994Study record on ClinicalTrials.gov
Providence Health Partners-Center for Clinical Research, Dayton. 937-297-8994
Type 2 diabetes study of NNC0662-0419
Where: Dayton
What: Tests whether an investigational medicine from Novo Nordisk, NNC0662-0419, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes.
Study record on ClinicalTrials.gov
Providence Center for Clinical Research, Dayton
Type 2 diabetes study of icovamenib
Where: Canton
What: Tests whether an investigational medicine from Biomea Fusion, icovamenib, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 70 with type 2 diabetes, BMI 25+.
Study record on ClinicalTrials.gov
Diabetes and Endocrinology Associates of Stark County, Canton
Type 2 diabetes study of semaglutide
Where: Cleveland
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 45 to 75 with type 2 diabetes, BMI 30+.
Call the site: 216-445-8354Study record on ClinicalTrials.gov
Cleveland Clinic, Cleveland. 216-445-8354
Other GLP-1 studies in Ohio (15)
Fatty liver disease with liver scarring study of survodutide
Where: Columbus, Mentor, Springboro and 1 more city
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
The Ohio State University Wexner Medical Center, Columbus. 833-602-2368
Great Lakes Gastroenterology, Mentor. 833-602-2368
ObjectiveHealth-DSI Research - Springboro, LLC, Springboro. 833-602-2368
Northshore Gastroenterology Research, Westlake. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Columbus, Mentor, Springboro and 1 more city
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
The Ohio State University Wexner Medical Center, Columbus. 833-602-2368
Great Lakes Gastroenterology, Mentor. 833-602-2368
ObjectiveHealth-DSI Research - Springboro, LLC, Springboro. 833-602-2368
Northshore Gastroenterology Research, Westlake. 833-602-2368
Fatty liver disease (MASLD) study of retatrutide
Where: Akron, Beavercreek, Brooklyn and 1 more city
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Call the site: 937-320-5050Study record on ClinicalTrials.gov
Akron Gastro Research, Akron
Dayton Gastroenterology - Beavercreek, Beavercreek. 937-320-5050
Clinical Research Institute of Ohio - Brooklyn, Brooklyn. 440-363-4000
CRIOH, Westlake. 440-363-4000
Show 12 more studies
Fatty liver disease (also called MASH or NASH) study of pemvidutide
Where: Springboro and Westlake
What: Tests whether a GLP-1 and glucagon medicine from Altimmune, pemvidutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18 to 75 with fatty liver disease (also called MASH or NASH), BMI 23+.
Study record on ClinicalTrials.gov
Altimmune Clinical Study Site, Springboro
Altimmune Clinical Study Site, Westlake
Ulcerative colitis study of tirzepatide
Where: Westlake
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Study record on ClinicalTrials.gov
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
Crohn's disease study of tirzepatide
Where: Westlake
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Study record on ClinicalTrials.gov
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
Alcohol use disorder study of semaglutide
Where: Cleveland
What: Tests whether a GLP-1 medicine, semaglutide, can help people with alcohol use disorder drink less.
Free to join
Who can join: Adults 18 to 80 with alcohol use disorder, BMI 21+.
Call the site: 216-231-3241Study record on ClinicalTrials.gov
Louis Stokes VA Medical Center, Cleveland, OH, Cleveland. 216-231-3241
Prehypertension study of orforglipron
Where: Columbus
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 614-487-2560Study record on ClinicalTrials.gov
Remington-Davis, Inc, Columbus. 614-487-2560
ASCVD study of semaglutide
Where: Wooster
What: Tests whether a GLP-1 medicine, semaglutide, can help people lower blood sugar.
Free to join
Who can join: Adults 40 to 80 with type 2 diabetes.
Call the site: 330-202-5700Study record on ClinicalTrials.gov
Wooster Heart Group, Wooster. 330-202-5700
Fatty liver disease with liver scarring study of tirzepatide
Where: Cleveland
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.
Free to join
Who can join: Adults 18 to 75 with fatty liver disease (MASLD) with liver scarring (fibrosis), BMI 35+.
Study record on ClinicalTrials.gov
Cleveland Clinic, Cleveland
Psoriasis study of tirzepatide
Where: Boardman
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.
Free to join
Who can join: Adults 18+ with psoriasis, BMI 27+.
Call the site: 330-422-3234Study record on ClinicalTrials.gov
Optima Research - Boardman, Boardman. 330-422-3234
Liver cirrhosis study of tirzepatide
Where: Cleveland
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.
Free to join
Who can join: Adults 18 to 70 with liver cirrhosis, BMI 35+.
Call the site: 216-636-5340Study record on ClinicalTrials.gov
Cleveland Clinic Main Campus, Cleveland. 216-636-5340
Atrial fibrillation study of tirzepatide
Where: Cleveland
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with atrial fibrillation lose weight.
Free to join
Who can join: Adults 18 to 80 with atrial fibrillation, BMI 27+.
Call the site: 216-445-4063Study record on ClinicalTrials.gov
Cleveland Clinic, Cleveland. 216-445-4063
Maturity-onset diabetes of the young (MODY) study of liraglutide
Where: Cincinnati
What: Tests whether a GLP-1 medicine, liraglutide, can help people with maturity-onset diabetes of the young (MODY) lower blood sugar.
Free to join
Who can join: Ages 10+ with maturity-onset diabetes of the young (MODY), BMI 18.5+.
Call the site: 513-636-0002Study record on ClinicalTrials.gov
Cincinnati Children's Hospital Medical Center, Cincinnati. 513-636-0002
Abdominal wall hernia study of semaglutide
Where: Cleveland
What: Tests a GLP-1 medicine, semaglutide, in people with abdominal wall hernia.
Free to join
Who can join: Adults 18+ with abdominal wall hernia, BMI 40+.
Call the site: 2164068573Study record on ClinicalTrials.gov
Cleveland Clinic Main Campus, Cleveland. 2164068573
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)